Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Intravenous lidocaine is commonly given through an intravenous (IV) line prior to injection of propofol to reduce the amount of pain during propofol injection. The investigators want to study if giving the lidocaine through the IV while the forearm on the same limb has a tourniquet applied to it to prevent "washing out" of the lidocaine prior to propofol injection helps reduce propofol injection pain.
The investigators expect that tourniquet lidocaine is superior to straight non-tourniquet lidocaine in reducing propofol injection pain. The investigators also wanted to determine the association of tourniquet duration on reduction of pain with propofol administration. Small studies indicate that 60 seconds of tourniquet lidocaine is superior to 30 seconds or less of tourniquet duration or mixed lidocaine/propofol for injection. The investigators suspect many clinicians do not use the 60-second tourniquet technique due to the extra time involved but hypothesize that a more practical application by applying the tourniquet as soon as the patient is positioned on the operating table will not only be more widely adopted by clinicians as it does not cause delay but also provide the necessary amount of time for benefit from the tourniquet. The investigators also wanted to record the time from tourniquet application to start of propofol administration, which the investigators predict would be at least 60 seconds to see if there is a correlation between duration of venous stasis of IV lidocaine and pain benefit.
Methods and Measures
Design This was conducted as a randomized controlled trial of two methods of administering lidocaine prior to propofol injection.
Setting The study setting was located within North Carolina Baptist Health, an academic medical center, in the Endoscopy Suite or Outpatient Surgery Center where subjects were scheduled to receive propofol as part of their sedation or anesthetic.
Sample Size The investigators estimated that 25 subjects in each of the two groups was required to test the hypothesis based on prior studies.
Interventions and Interactions
The investigators used two groups:
For both groups, no premedication was given, which is the normal practice for these procedures. Study procedures involved placing a 20 gauge intravenous (IV) catheter in a vein distal to the mid forearm. Venous occlusion was achieved by either a latex free tourniquet or McKesson Quick Release tourniquet applied to the forearm 10cm distal to the elbow joint. Tourniquet pressure was somewhat variable but sufficient to cause venous stasis as confirmed by no flow of hanging IV fluid. Injections were delivered at roughly 1 ml/sec.
Schedule of events in the study (all performed by 1 of the 2 investigators:
Day of procedure: holding area
Day of procedure: procedure area
-Accompany subject to the operating or procedure room, perform protocol from the group to which the subjects were assigned, while noting outcome measures such as self-described discomfort and observer graded discomfort
Day of procedure: recovery area
-Revisit subject in recovery 30 minutes after their procedure to determine post-procedure recall of discomfort
Post-study period
Analyze data
Analytical Plan The investigators will analyze results initially using descriptive statistics. Comparison between groups was done using chi square tests for proportions, and t-tests or ANOVA procedures for continuous variables. Regression analysis was performed to identify independent outcome predictors. Other inferential statistical analysis was conducted as appropriate.
Informed Consent One of the two investigators obtained signed informed consent from each subject. This was performed in the holding room prior to the procedure since most subjects had their pre-procedure examination performed in the holding room and were not seen prior to the day of their procedure.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intravenous lidocaine: flushed | Active Comparator | Lidocaine injection flushed |
|
| Intravenous lidocaine: tourniquet | Experimental | Lidocaine injection tourniquet |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Lidocaine injection flushed | Drug | The investigator administers IV lidocaine and flushes it into the subject prior to administering propofol. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Patient Expression of Pain | Patient's verbal rating of pain during injection (see link to study protocol) We used a Verbal Rating Scale from the patient that self-described discomfort level during injection using question: How would you rate your pain using None, Mild, Moderate, Severe and record it on this 4-point scale:
| During injection at beginning of study; lasts 10 seconds one time only |
| Measure | Description | Time Frame |
|---|---|---|
| Subject's Recall of Injection Discomfort | Investigator asks patient if they recall discomfort during injection after the procedure. Patient's verbal rating and recall of pain during injection. We used a Verbal Rating Scale from the patient that self-described discomfort level during injection using question: How would you rate your pain using None, Mild, Moderate, Severe and record it on this 4-point scale:
|
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Timothy N Harwood, MD | Wake Forest University Health Sciences | Principal Investigator |
| Patrick Grace, MD | Wake Forest University Health Sciences | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| North Carolina Baptist Hospital | Winston-Salem | North Carolina | 27612 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Subjects were approached after they were scheduled for colonoscopy or minor procedures and appeared in the holding area for procedures in which propofol sedation or induction of general anesthesia was used.
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Intravenous Lidocaine: Flushed | Lidocaine injection flushed Lidocaine injection flushed: The investigator administers IV lidocaine and flushes it into the subject prior to administering propofol. |
| FG001 | Intravenous Lidocaine: Tourniquet | Lidocaine injection tourniquet Lidocaine injection tourniquet: Intravenous lidocaine: tourniquet |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Subjects were eligible is schedule for procedures in which they would receive propofol for sedation or induction. Subjects included a general local population from the Piedmont Triad of North Carolina.
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Intravenous Lidocaine: Flushed | Lidocaine injection flushed Lidocaine injection flushed: The investigator administers IV lidocaine and flushes it into the subject prior to administering propofol. |
| BG001 | Intravenous Lidocaine: Tourniquet |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Patient Expression of Pain | Patient's verbal rating of pain during injection (see link to study protocol) We used a Verbal Rating Scale from the patient that self-described discomfort level during injection using question: How would you rate your pain using None, Mild, Moderate, Severe and record it on this 4-point scale:
| Posted | Mean | Standard Deviation | units on a scale | During injection at beginning of study; lasts 10 seconds one time only |
|
We studied the subjects in this time frame: 1) Initiated contact with them in the holding area just prior to their procedure. 2) We assessed their verbal expression of discomfort and their display of discomfort (outcomes 1 and 2) during propofol injection and up to 30 seconds after injection 3) We assessed their recall of discomfort approximately 30 minutes after their procedure while they were in the recovery area. 4) They were then discharged home without further involvement in the trial.
Patients were interviewed in the recovery room at least 30 minutes after their procedure by one of the investigators, and they were called the next business day by a recovery room nurse for followup and asked about any adverse events they experienced after discharge.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Intravenous Lidocaine: Flushed | Lidocaine injection flushed Lidocaine injection flushed: The investigator administers IV lidocaine and flushes it into the subject prior to administering propofol. |
Not provided
Not provided
Results became clear at total number of subject =25.
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Timothy N. Harwood MD | Wake Forest University School of Medcine | 3367164498 | tharwood@wakehealth.edu |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP_ICF | Yes | Yes | Yes | Study Protocol, Statistical Analysis Plan, and Informed Consent Form | Nov 30, 2016 | Nov 6, 2017 | Prot_SAP_ICF_000.pdf |
Not provided
| ID | Term |
|---|---|
| D010146 | Pain |
| ID | Term |
|---|---|
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D008012 | Lidocaine |
| D014111 | Tourniquets |
| ID | Term |
|---|---|
| D000083 | Acetanilides |
| D000813 | Anilides |
| D000577 | Amides |
| D009930 | Organic Chemicals |
| D000814 |
Not provided
Not provided
A randomized, controlled trial of two methods of administering lidocaine prior to propofol injection
Not provided
Not provided
The participant is not told which group they are randomized to. However, a tourniquet is applied in the experimental group, thus some subjects may reason that they are in the experimental group. The study coordinator is aware which group the subject is in.
|
| Lidocaine injection tourniquet | Drug | Intravenous lidocaine: tourniquet |
|
|
| This occurs 30 minutes after the subject's procedure is finished in the recovery room; lasts 30 seconds one time only |
| Investigators Rating of Patient Discomfort | Investigator rates patient's nonverbal display of discomfort. Investigator Assessments: Induction Discomfort Scale (during injection and within 5 seconds after injection)
| During injection at beginning of study period; lasts 10 seconds one time only |
Lidocaine injection tourniquet Lidocaine injection tourniquet: Intravenous lidocaine: tourniquet |
| BG002 | Total | Total of all reporting groups |
| Participants |
|
| Age, Continuous | Mean | Standard Deviation | years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Race (NIH/OMB) | Count of Participants | Participants |
|
| Region of Enrollment | Number | participants |
|
| Pain score at IV prior to procedure | Count of Participants | Participants |
|
| Intravenous Lidocaine: Tourniquet |
Lidocaine injection tourniquet Lidocaine injection tourniquet: Intravenous lidocaine: tourniquet |
|
|
| Secondary | Subject's Recall of Injection Discomfort | Investigator asks patient if they recall discomfort during injection after the procedure. Patient's verbal rating and recall of pain during injection. We used a Verbal Rating Scale from the patient that self-described discomfort level during injection using question: How would you rate your pain using None, Mild, Moderate, Severe and record it on this 4-point scale:
| Posted | Mean | Standard Deviation | units on a scale | This occurs 30 minutes after the subject's procedure is finished in the recovery room; lasts 30 seconds one time only |
|
|
|
| Secondary | Investigators Rating of Patient Discomfort | Investigator rates patient's nonverbal display of discomfort. Investigator Assessments: Induction Discomfort Scale (during injection and within 5 seconds after injection)
| Posted | Mean | Standard Deviation | units on a scale | During injection at beginning of study period; lasts 10 seconds one time only |
|
|
|
| 0 |
| 25 |
| 0 |
| 25 |
| 0 |
| 25 |
| EG001 | Intravenous Lidocaine: Tourniquet | Lidocaine injection tourniquet Lidocaine injection tourniquet: Intravenous lidocaine: tourniquet | 0 | 25 | 0 | 25 | 0 | 25 |
Not provided
Not provided
Not provided
| Aniline Compounds |
| D000588 | Amines |
| D004864 | Equipment and Supplies |